GSA Capital Partners’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $298K | Sell |
|
|||||
|
2025
Q1 | $590K | Sell |
|
|||||
|
2024
Q4 | $571K | Buy |
|
|||||
|
2024
Q3 | $452K | Sell |
|
|||||
|
2024
Q2 | $983K | Sell |
|
|||||
|
2024
Q1 | $1.11M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $97K | Sell |
|
|||||
|
2023
Q2 | $354K | Buy |
|
|||||
|
2023
Q1 | $112K | Sell |
|
|||||
|
2022
Q4 | $348K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $483K | Buy |
|
|||||
|
2022
Q1 | $450K | Buy |
|
|||||
|
2021
Q4 | $160K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $569K | Buy |
|
|||||
|
2021
Q1 | $167K | Sell |
|
|||||
|
2020
Q4 | $181K | Sell |
|
|||||
|
2020
Q3 | $209K | Buy |
|
|||||
|
2020
Q2 | $238K | Sell |
|
|||||
|
2020
Q1 | $342K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $368K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $235K | Buy |
|